However, overexpression of TFAP2C in NSCLC leads to excessive cell cycle activation which promotes tumor aggressiveness: the proposed model of action consists of simultaneous induction of oncogenic miR-183 and down-regulation of suppressive miR-33a. The gene discussed is TFAP2C; the disease is neoplasm.